SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-026615
Filing Date
2024-02-07
Accepted
2024-02-07 15:43:55
Documents
18
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d736760d8k.htm   iXBRL 8-K 35510
2 EX-4.1 d736760dex41.htm EX-4.1 82034
3 EX-4.2 d736760dex42.htm EX-4.2 91885
4 EX-10.1 d736760dex101.htm EX-10.1 185233
5 EX-10.2 d736760dex102.htm EX-10.2 87308
  Complete submission text file 0001193125-24-026615.txt   732871

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240206.xsd EX-101.SCH 2840
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240206_lab.xml EX-101.LAB 17977
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240206_pre.xml EX-101.PRE 11251
20 EXTRACTED XBRL INSTANCE DOCUMENT d736760d8k_htm.xml XML 3663
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24604129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)